Wenjia Li
Research Subjects
Wenjia Li has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Keyi Wu
Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, China
2 shared publicationsLijuan Bao
Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, China
2 shared publicationsYihong Zhao
Department of Breast Surgery, China-Japan Union Hospital of Jilin University, Changchun, China
2 shared publications- Caijun Zhao
Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, China
1 shared publication - Changlong Song
Department of Breast Surgery, China-Japan Union Hospital of Jilin University
1 shared publication Chongshan Yuan
Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, China
1 shared publication
Latest Publications
- Open Access
- 26 November 2025
- Published by Springer Nature in Microbiome
- Vol. 14 (1)
Phytosphingosine contributes gut microbiota metabolism to alleviate low-grade endotoxemia-induced mastitis
Recently, evidence has indicated that mastitis is closely associated with the ruminal dysbiosis caused by subacute ruminal acidosis (SARA) and subsequent l
- 26 November 2025
- Published by Springer Nature in Microbiome
- Vol. 14 (1)
Open AccessPhytosphingosine contributes gut microbiota metabolism to alleviate low-grade endotoxemia-induced mastitis
Recently, evidence has indicated that mastitis is closely associated with the ruminal dysbiosis caused by subacute ruminal acidosis (SARA) and subsequent l
- 29 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 140, 112818
Ferroptosis is involved in Staphylococcus aureus-induced mastitis through autophagy activation by endoplasmic reticulum stress
- 29 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 140, 112818
Ferroptosis is involved in Staphylococcus aureus-induced mastitis through autophagy activation by endoplasmic reticulum stress
- 24 August 2023
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 202 (1) , 1-9
Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in patients with breast cancer: a meta-analysis
Objective Breast cancer patients receiving neoadjuvant therapy (NAT) are in need of a more patient-friendly imaging modality such as contrast-enhanced mammography (CEM) for monitoring therapy response. The purpose of this study was to conduct a meta-analysis to compare the diagnostic performances of CEM and contrast-enhanced magnetic resonance imaging (CE-MRI) for assessing pathological complete response (pCR) in these patients. Methods The PubMed, Embase, and Cochrane Library databases were searched through March 2023 to identify studies reporting a head-to-head comparison of CEM and CE-MRI in detecting pCR in breast cancer patients receiving NAT. Pooled diagnostic performance was calculated using a bivariate random-effects model, and an AUC was derived for each test from hierarchic summary ROC analysis. Results Six studies with 328 patients were included. Pooled sensitivity, specificity, and diagnostic odds ratio (DOR) were 93% (95% CI 84–97%), 68% (95% CI 60–76%), and 29.29 (95% CI 11.41–75.18) for CEM versus 84% (95% CI 62–95%), 80% (95% CI 71–87%), and 21.39 (95% CI 5.94–77.13) for CE-MRI. The AUC was 0.85 (95% CI 0.82–0.88) for CEM and 0.85 (95% CI 0.82–0.88) for CE-MRI. Conclusion This meta-analysis of head-to-head comparison studies showed that CEM provides an equivalent diagnostic accuracy to CE-MRI in identification of pCR in breast cancer patients receiving NAT. The results support the increasing use of CEM in this setting and would encourage future studies to validate CEM as a suitable replacement for MRI.
- 24 August 2023
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 202 (1) , 1-9
Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in patients with breast cancer: a meta-analysis
Objective Breast cancer patients receiving neoadjuvant therapy (NAT) are in need of a more patient-friendly imaging modality such as contrast-enhanced mammography (CEM) for monitoring therapy response. The purpose of this study was to conduct a meta-analysis to compare the diagnostic performances of CEM and contrast-enhanced magnetic resonance imaging (CE-MRI) for assessing pathological complete response (pCR) in these patients. Methods The PubMed, Embase, and Cochrane Library databases were searched through March 2023 to identify studies reporting a head-to-head comparison of CEM and CE-MRI in detecting pCR in breast cancer patients receiving NAT. Pooled diagnostic performance was calculated using a bivariate random-effects model, and an AUC was derived for each test from hierarchic summary ROC analysis. Results Six studies with 328 patients were included. Pooled sensitivity, specificity, and diagnostic odds ratio (DOR) were 93% (95% CI 84–97%), 68% (95% CI 60–76%), and 29.29 (95% CI 11.41–75.18) for CEM versus 84% (95% CI 62–95%), 80% (95% CI 71–87%), and 21.39 (95% CI 5.94–77.13) for CE-MRI. The AUC was 0.85 (95% CI 0.82–0.88) for CEM and 0.85 (95% CI 0.82–0.88) for CE-MRI. Conclusion This meta-analysis of head-to-head comparison studies showed that CEM provides an equivalent diagnostic accuracy to CE-MRI in identification of pCR in breast cancer patients receiving NAT. The results support the increasing use of CEM in this setting and would encourage future studies to validate CEM as a suitable replacement for MRI.